Cavanaugh Sarah

Track

Insider profile

Performance

Overall performance
3.0
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 63% 68% 82%
Transactions
4 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 661%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Cavanaugh Sarah's trades of Celldex Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
400.35
Quantity 7,696
Value US$3,644,162
Transaction date
Purchase
Price
4.83
Quantity 1,050 +331.2%
Value US$5,072
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-03 2024-05-30
S Sale
41,264 +27.9%
202.24
US$4,675,453 		41,264 +27.9% 202.24 US$4,675,453
2024-05-30 2024-05-30
PrS Proposed sale
7,696
400.35
US$3,644,162 		7,696 400.35 US$3,644,162
2022-08-19 2022-08-18
S Sale
73,531 -8.3%
22.35
US$335,951 		73,531 -8.3% 22.35 US$335,951
2022-08-19 2022-08-17
S Sale
31,312 -96.1%
36.73
US$1,150,221 		31,312 -96.1% 36.73 US$1,150,221
2021-12-10 2021-12-08
PlS Planned sale
7,323 -94.7%
40.00
US$292,920 		7,323 -94.7% 40.00 US$292,920
2021-11-03 2021-11-01
PlS Planned sale
2,120 -83.9%
41.62
US$88,232 		2,120 -83.9% 41.62 US$88,232
2021-11-03 2021-11-01
PlS Planned sale
901 -26.3%
43.06
US$38,798 		901 -26.3% 43.06 US$38,798
2021-11-03 2021-11-01
PlS Planned sale
4,302 -55.6%
44.11
US$189,774 		4,302 -55.6% 44.11 US$189,774
2020-06-11 2020-06-10
B Purchase
1,050 +331.2%
4.83
US$5,072 		1,050 +331.2% 4.83 US$5,072